Terms: = Leukemia AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
52 results:
1. Systems Biology for Drug Target Discovery in Acute Myeloid leukemia.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Zgoda V
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731835
[TBL] [Abstract] [Full Text] [Related]
2. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid leukemia.
Pepeler MS; Tıglıoglu M; Dagdas S; Ozhamamcıoglu E; Han U; Albayrak A; Aydın MS; Korkmaz G; Pamukcuoğlu M; Ceran F; Albayrak M; Ozet G
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e161-e167. PubMed ID: 38342726
[TBL] [Abstract] [Full Text] [Related]
4. Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
Moore-Vasram S; Sawhney M; Houlden RL; Groome PA; Goldie C; Li W; Hay AE; Tranmer J
Can J Diabetes; 2024 Apr; 48(3):195-203.e1. PubMed ID: 38211830
[TBL] [Abstract] [Full Text] [Related]
5. Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Ravandi F; Döhner H; Wei AH; Montesinos P; Pfeilstöcker M; Papayannidis C; Lai Y; Wang K; See WL; de Menezes DL; Petrlik E; Prebet T; Roboz GJ
Br J Haematol; 2024 Mar; 204(3):877-886. PubMed ID: 37952982
[TBL] [Abstract] [Full Text] [Related]
6. Niosomes based formulation containing tenoxicam: A newer solution for the rheumatic diseases.
Maheshwari R; Sharma M; Chidrawar VR
Ann Pharm Fr; 2024 May; 82(3):473-482. PubMed ID: 37923009
[TBL] [Abstract] [Full Text] [Related]
7. [Efficacy and safety of dexcitabine combined with HAAG regimen in the treatment of recurrent acute myeloid leukemia].
Wu XF; Li CC; Li TT; Sun L; Lu J; Ran XH
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(13):981-985. PubMed ID: 36990713
[No Abstract] [Full Text] [Related]
8. [Effect of High-Volume Leukapheresis on Hematological Indexes of Patients with Hyperleukocytic leukemia].
Wu Y; Wu YJ; Li HS; Chen BC; Liu Y; Wu YQ; Liang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1331-1336. PubMed ID: 36208231
[TBL] [Abstract] [Full Text] [Related]
9. MiR-641 Exacerbates the Progression of Ischemic Stroke Through the MCL-1/Wnt/β-Catenin Pathway.
Pan Q; Li K; Xue L; Cheng X; Zhou Q
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975488
[TBL] [Abstract] [Full Text] [Related]
10. Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Tanaka N; Mori S; Kiyotani K; Ota Y; Gotoh O; Kusumoto S; Nakano N; Suehiro Y; Ito A; Choi I; Ohtsuka E; Hidaka M; Nosaka K; Yoshimitsu M; Imaizumi Y; Iida S; Utsunomiya A; Noda T; Nishikawa H; Ueda R; Ishida T
Haematologica; 2022 Oct; 107(10):2418-2431. PubMed ID: 35417939
[TBL] [Abstract] [Full Text] [Related]
11. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
[TBL] [Abstract] [Full Text] [Related]
12. What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?
Komrokji R; Al Ali N; Padron E; Lancet J; Nazha A; Steensma D; DeZern A; Roboz G; Garcia-Manero G; Sekeres MA; Sallman D
Leuk Lymphoma; 2021 Nov; 62(11):2762-2767. PubMed ID: 34114922
[TBL] [Abstract] [Full Text] [Related]
13. Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome.
Huson SM; Staab T; Pereira M; Ward H; Paredes R; Evans DG; Baumhoer D; O'Sullivan J; Cheesman E; Schindler D; Meyer S
Fam Cancer; 2022 Jan; 21(1):85-90. PubMed ID: 33219493
[TBL] [Abstract] [Full Text] [Related]
14. [Deleted in lymphocytic leukemia 1 promoted proliferation and apoptosis of nephroblastoma cells through regulating miR-513a-5p and RANBP2 pathway].
Zhao JL; Zhao LL; Niu WZ; Ding XC; Zhang WL
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):849-855. PubMed ID: 33113626
[No Abstract] [Full Text] [Related]
15. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
[TBL] [Abstract] [Full Text] [Related]
16. Fractions of
Soni KK; Meshram D; Lawal TO; Patel U; Mahady GB
Curr Drug Discov Technol; 2021; 18(1):95-104. PubMed ID: 31985381
[TBL] [Abstract] [Full Text] [Related]
17. Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.
Pastor-Galán I; Hernández-Boluda JC; Correa JG; Alvarez-Larrán A; Ferrer-Marín F; Raya JM; Ayala R; Velez P; Pérez-Encinas M; Estrada N; García-Gutiérrez V; Fox ML; Payer A; Kerguelen A; Cuevas B; Durán MA; Ramírez MJ; Gómez-Casares MT; Mata-Vázquez MI; Mora E; Martínez-Valverde C; Arbelo E; Angona A; Magro E; Antelo ML; Somolinos N; Cervantes F;
Med Clin (Barc); 2020 Aug; 155(4):152-158. PubMed ID: 31980217
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation.
Yamamoto C; Nakashima H; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Mashima K; Nagayama T; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Sugimoto M; Ishihara Y; Ashizawa M; Hatano K; Sato K; Oh I; Fujiwara SI; Ueda M; Ohmine K; Muroi K; Kanda Y
Blood Adv; 2019 Nov; 3(21):3266-3277. PubMed ID: 31698458
[TBL] [Abstract] [Full Text] [Related]
19. [Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].
Liu Y; Mi RH; Chen L; Yuan FF; Yin QS; Fu YW; Zhu XH; Liu XJ; Zhang YL; Zhang WL; Wei XD
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):738-743. PubMed ID: 31648474
[No Abstract] [Full Text] [Related]
20. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
Oosterom N; de Jonge R; Smith DEC; Pieters R; Tissing WJE; Fiocco M; van Zelst BD; van den Heuvel-Eibrink MM; Heil SG
PLoS One; 2019; 14(9):e0221591. PubMed ID: 31527879
[TBL] [Abstract] [Full Text] [Related]
[Next]
